Repaglinide

Repaglinide is a short-acting insulin secretagogue, which often results in considerable inter-individual variability in therapeutic efficacy when widely used in clinical setting. Repaglinide is used for diabetes mellitus type 2. Both repaglinide and metformin were effective in glycaemic control in new onset patients with type 2 diabetes in China. Repaglinide had no effect on insulin sensitivity, but it improved β-cell function.